Introduction
Astrocytes are critical components of neural circuits and are known to be involved in brain disorders [1, 2] . Astrocytes may represent approximately 40% of all brain cells and tile the nervous system [3] . In mice, cortical astrocytes are seen soon after neurogenesis at around embryonic day 16, and, following migration along radial glia, they occupy well-defined territories with properties and locations that may be tailored to the needs of nearby neurons [4] . Each individual mature astrocyte comprises a cell body, six or so major branches, a thick blood vessel-associated endfoot, and myriad finer branchlets and leaflets [3] . Although astrocytes are highly complex structures, they are not polarized like neurons and their complexity is largely equivalent throughout individual territories [5] that overlap very little in healthy rodent tissue [6] or in models of trauma [7] . It is these stereotypical features that give rise to 'bushy' astrocyte appearances in healthy tissue (Figure 1 ). The loss of some of these anatomical features has been documented in disease [8] , including HD [9] .
There has been progress in deciphering how astrocytes contribute to the nervous system since the first electrophysiological studies approximately 50 years ago [10, 11] . Established, proposed, and debated roles for astrocytes include neurovascular coupling, stabilizing the bloodbrain barrier, regulation of synaptic function, ion homeostasis, neurotransmitter clearance, metabolic support of neurons, regulation of action potential waveforms, synaptic plasticity, and regulation of behaviors, such as sleep [3, [12] [13] [14] [15] [16] [17] [18] . In addition, it is now well established that astrocytes respond to all forms of injury, trauma, and infection via a process termed 'astrogliosis' [19] .
Herein, we summarize recent work that is beginning to unravel how astrocyte dysfunction accompanies and contributes to neuronal deficits in HD model mice (Table 1) . We do not
Trends
Astrocytes are involved in HD.
Astrocyte dysfunctions contribute to HD pathophysiology in mice.
Transplanted astrocytes produce therapeutic benefit in HD model mice.
Targeting astrocyte dysfunction may provide new therapeutic targets in HD. 
